加载中
Vyome Holdings, Inc. operates as a healthcare firm currently in its clinical development phase, concentrating on the creation of innovative medicinal treatments designed to address both immuno-inflammatory conditions and infrequent disorders. Founded in 2017, the company extends its market reach throughout the United States and into global territories, headquartered in Princeton, New Jersey.
收盘时
US$2.01
−US$0.08 · -3.83%
盘后
US$2.00
−US$0.01 · -0.50%
10月12日 16:00 ET
盘中时间采用ET。市场数据可能有所延迟。
Vyome Holdings, Inc. operates as a healthcare firm currently in its clinical development phase, concentrating on the creation of innovative medicinal treatments designed to address both immuno-inflammatory conditions and infrequent disorders. Founded in 2017, the company extends its market reach throughout the United States and into global territories, headquartered in Princeton, New Jersey.
日内区间
当前US$2.01
52周区间
当前US$2.01
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
卖出
估值
41
合理估值
情绪
49
多空交织
风险
73
高风险
动量
32
动能减弱
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
Vyome Holdings, Inc. operates as a healthcare firm currently in its clinical development phase, concentrating on the creation of innovative medicinal treatments designed to address both immuno-inflammatory conditions and infrequent disorders. Founded in 2017, the company extends its market reach throughout the United States and into global territories, headquartered in Princeton, New Jersey.
日内区间
当前US$2.01
52周区间
当前US$2.01
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 31.97万 USD | 800.6万 USD | 867.8万 USD | 1124万 USD | 1360万 USD |
| 销货成本 | 11.29万 USD | 294.9万 USD | 313万 USD | 443.8万 USD | 525.2万 USD |
| 毛利 | 20.68万 USD | 505.7万 USD | 554.8万 USD | 680.2万 USD | 834.8万 USD |
| 研究与开发 | 58.83万 USD | 180.3万 USD | 231.5万 USD | 253.7万 USD | 236.9万 USD |
| 销售、一般及管理费用 | 236.56万 USD | 992.2万 USD | 1787.2万 USD | 3134.3万 USD | 3321.2万 USD |
| 营业费用 | 295.38万 USD | 1278.5万 USD | 2018.7万 USD | 3388万 USD | 6623万 USD |
| 利息收入 | — | 1.4万 USD | 2.6万 USD | — | — |
| 利息支出 | 14.66万 USD | — | — | 11.3万 USD | 83.2万 USD |
| 折旧和摊销 | 1.2万 USD | 2.2万 USD | 15.4万 USD | 215.3万 USD | 197.1万 USD |
| 营业利润 | −274.7万 USD | −772.8万 USD | −1463.9万 USD | −2707.8万 USD | −5788.2万 USD |
| 净利润 | −1026.2万 USD | −713万 USD | −1138.7万 USD | −4621.4万 USD | −6314.6万 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
评级样本有限，仅3项
报告持有此股票敞口的交易所交易基金。
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
